NeurOptics Pupillometer Systems provide trendable, accurate and objective measurement of pupil size and reactivity in any patient requiring a neurological examination. The NPi Pupillometer expresses pupil reactivity numerically as the Neurological Pupil Index— NPi®. NPi values range from 0 to 4.9, with scores below 3 indicating abnormalities. The presence of an abnormal NPi value holds significant implications for clinicians managing critically ill patients with brain injuries or those at risk of secondary neurological damage.
NeurOptics’ quantitative automated NPi Pupillometer provides a reliable measurement of pupil size and reactivity and tracks changes over time, allowing for earlier intervention for patients with brain injury and those at risk of secondary neurological injury. The NPi Pupillometer supports neurological examination in adult and pediatric patients across a broad spectrum of diagnoses, including traumatic brain injury, stroke, seizure, or other neurological events after cardiac arrest and other medical conditions.
Headquartered in Irvine, California, NeurOptics is the worldwide leader in NPi Pupillometry. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technology for critical care medicine, neurology, neurosurgery, emergency medicine, and research. The NeurOptics’ NPi Pupillometer has been included in more than 130 clinical studies, adopted in over 700 hospitals in the U.S., and is represented in more than 40 countries worldwide. For more information, visit www.NeurOptics.com. Follow NeurOptics on Facebook, LinkedIn, and X.